A randomized phase 2 study combining midostaurin, low-dose cytarabine and venetoclax in newly diagnosed AML ≥60 years
用户rWEzDuPXzy98
11小时前
22
10
已完结
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-11-16 10:06:20 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
其他信息:
出版社: American Society of Hematology
作者: Chong Chyn Chua; Wei-Hsun Hsun Hsu; Anoop K. Enjeti; Ashish Bajel; Paula Marlton; Shaun A Fleming; Devendra K. Hiwase; Chun-kei-kris Kris Ma; Peter J. Browett; Carolyn S. Grove; ShuhYing Tan; Travis Perera; Jad Othman; Hannah Rose; Julian P Cooney; Edward S Morris; Derek McCulloch; Kate Mason; Rachel M Koldej; Amanda Johnston; Stephen B Ting; David Ritchie; Natasha S Anstee; John Reynolds; Andrew H Wei
全文下载地址: https://ashpublications.org/blood/article-pdf/doi/10.1182/blood.2026035389/2595842/blood.2026035389.pdf
